![]() |
![]() |
Legal status
Patent lapsed (non-payment of fees)
(51) | INT.CL. | C07K 16/28 | (2006.01) |
C07K 16/30 | (2006.01) | ||
A61P 35/00 | (2006.01) | ||
A61K 47/48 | (2006.01) | ||
A61K 39/395 | (2006.01) |
(11) | Number of the document | 2242772 |
(13) | Kind of document | T |
(96) | European patent application number | 08865838.0 |
Date of filing the European patent application | 2008-12-23 | |
(97) | Date of publication of the European application | 2010-10-27 |
(45) | Date of publication and mention of the grant of the patent | 2014-11-26 |
(46) | Date of publication of the claims translation | 2015-03-25 |
(86) | Number | PCT/EP2008/068267 |
Date | 2008-12-23 |
(87) | Number | WO 2009/080830 |
Date | 2009-07-02 |
(30) | Number | Date | Country code |
16620 P | 2007-12-26 | US | |
87466 P | 2008-08-08 | US | |
87590 P | 2008-08-08 | US |
(72) |
KRAUS, Elmar, DE
BRUECHER, Christoph, DE
DAELKEN, Benjamin, DE
ZENG, Steffen, DE
OSTERROTH, Frank, DE
UHEREK, Christoph, DE
AIGNER, Silke, DE
GERMER, Matthias, DE
SCHULZ, Gregor, DE
HAEDER, Thomas, DE
|
(73) |
Biotest AG,
Landsteinerstr. 5, 63303 Dreieich,
DE
Immunogen, Inc., 830 Winter Street, Waltham, MA 02451-1477, US |
(74) |
Ramunė GARŠVIENĖ,
Dūkštų g. 28-20, LT-07171 Vilnius,
LT
|
(54) | Imunokonjugatai, nukreipti į CD138, ir jų panaudojimas |
IMMUNOCONJUGATES TARGETING CD138 AND USES THEREOF |
Payment date | Validity (years) | Amount | |
2018-11-26 | 11 | 289.00 EUR |
Patent lapsed (non-payment of fees) | ||
Invalidation date | 2019-12-23 |